P-97 Updated results of HGCSG1603: A phase 2 trial of ramucirumab plus irinotecan combination therapy as second-line treatment for patients with advanced gastric cancer
Title:
P-97 Updated results of HGCSG1603: A phase 2 trial of ramucirumab plus irinotecan combination therapy as second-line treatment for patients with advanced gastric cancer
Author:
Nakamura, M. Kawamoto, Y. Yuki, S. Sawada, K. Muto, O. Sogabe, S. Shindo, Y. Ishiguro, A. Sato, A. Tsuji, Y. Dazai, M. Okuda, H. Sasaki, T. Harada, K. Nakatsumi, H. Iuchi, K. Sakata, Y. Komatsu, Y.